- Affirmative Recovery
- Alternative Dispute Resolution
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Childhood Sexual Abuse Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Wealth Planning, Administration, and Disputes
-
June 24, 2020Aaron Sheanin Named to Inaugural List of Daily Journal Top Antitrust Lawyers
-
June 19, 2020Message from the Robins Kaplan Executive Board
-
June 15, 2020Iam Patent 1000 Recommends Robins Kaplan for Patent Litigation for Tenth Consecutive Year
-
July 21, 2020Discovering a Hidden Revenue Stream: Recoveries from Antitrust Class Action Settlements in Economic Downturn
-
August 18, 2020Discovering a Hidden Revenue Stream: Recoveries from Antitrust Class Action Settlements in Economic Downturn
-
September 10, 2020Volunteer Lawyers Network Riverfront Celebration 2020
-
Summer 2020The Brave New World of Virtual Notarization
-
Summer 2020What Could be the Harm? Minnesota's Harmless Error Statute
-
Summer 2020What's a Fiduciary To Do? Considerations for Periods of Uncertainty
Regulating Personalized Medicine
May 1, 2015
The Obama administration's recently announced "Precision Medicine Initiative" will benefit not just from advances in genomics—which allow for an entire human genome to be sequenced in less than a day—but also from significant advances in computing power, the prevalence of electronic health records and even from the 160 million or so smartphones in the hands of U.S. consumers. The plan? To have 1 million volunteers share their genetic data, biological samples and diet and lifestyle information, and to link the data to their electronic health records. That is not as far-fetched a proposition as it might seem.
Reproduced with permission from Life Sciences Law & Industry Report, 9 LSLR 512, 05/01/2015. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.